Winton Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.9M Buy
+509,862
New +$6.1M 0.22% 103
2023
Q2
Sell
-53,673
Closed -$1.26M 1019
2023
Q1
$1.26M Sell
53,673
-11,676
-18% -$314K 0.08% 359
2022
Q4
$1.83M Sell
65,349
-17,610
-21% -$450K 0.12% 223
2022
Q3
$1.94M Buy
82,959
+16,314
+24% +$493K 0.13% 211
2022
Q2
$2.25M Buy
66,645
+21,467
+48% +$752K 0.12% 233
2022
Q1
$1.58M Buy
45,178
+21,649
+92% +$740K 0.08% 316
2021
Q4
$716K Buy
+23,529
New +$766K 0.04% 564

Other funds holding OGN

Winton Group's OGN Position: Q2 2026 in Review

Winton Group opened a new position in Organon & Co (OGN) in Q2 2026: 509,862 shares worth $6.9M. The stake represents 0.22% of the portfolio and ranks #103 among its holdings. This is a return to the name: Winton Group previously reported a position in OGN as recently as Q1 2023.

Winton Group first reported a position in OGN in Q4 2021 and has held it in 7 quarters since. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Winton Group held 509,862 shares of Organon & Co worth $6.9M as of Q2 2026.
  • Organon & Co was a new Winton Group position in Q2 2026.
  • Organon & Co made up 0.22% of Winton Group's portfolio in Q2 2026, its #103 holding.
  • Winton Group first reported a position in Organon & Co in Q4 2021 and has held it in 7 quarters since.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.